tradingkey.logo
搜索

Exicure Inc

XCUR
添加自选
1.600USD
+0.030+1.91%
收盘 07-31 16:00美东报价延迟15分钟
10.20M总市值
亏损市盈率 TTM

关于 Exicure Inc 公司

Exicure, Inc. is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The Company, through GPCR Therapeutics USA Inc. (GPCR USA), is focused on developing and commercializing an intellectual property and patents related to G-Protein Coupled Receptors. GPCR USA is conducting a Phase II clinical trial for a blood cancer treatment involving GPC-100 (Burixafor). The Company is also exploring strategic alternatives to maximize stockholder value.

Exicure Inc简介

公司代码XCUR
公司名称Exicure Inc
上市日期May 09, 2018
CEOYoo (Andy)
员工数量7
证券类型Ordinary Share
年结日May 09
公司地址2430 N. Halsted St.
城市CHICAGO
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编60614
电话18476731707
网址https://www.exicuretx.com/
公司代码XCUR
上市日期May 09, 2018
CEOYoo (Andy)

Exicure Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Dongho Lee
Mr. Dongho Lee
Independent Director
Independent Director
--
--
Mr. Andy Yoo
Mr. Andy Yoo
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Seung Ik Baik
Mr. Seung Ik Baik
Chief Financial Officer, Secretary, Director
Chief Financial Officer, Secretary, Director
--
--
Mr. Sangjn Yeo
Mr. Sangjn Yeo
Independent Director
Independent Director
--
--
Ms. Aejin Hwang
Ms. Aejin Hwang
Independent Director
Independent Director
--
--
Dr. Josephine (Pina) Cardarelli, Ph.D.
Dr. Josephine (Pina) Cardarelli, Ph.D.
President, Chief Scientific Officer
President, Chief Scientific Officer
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Dongho Lee
Mr. Dongho Lee
Independent Director
Independent Director
--
--
Mr. Andy Yoo
Mr. Andy Yoo
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Seung Ik Baik
Mr. Seung Ik Baik
Chief Financial Officer, Secretary, Director
Chief Financial Officer, Secretary, Director
--
--
Mr. Sangjn Yeo
Mr. Sangjn Yeo
Independent Director
Independent Director
--
--
Ms. Aejin Hwang
Ms. Aejin Hwang
Independent Director
Independent Director
--
--
Dr. Josephine (Pina) Cardarelli, Ph.D.
Dr. Josephine (Pina) Cardarelli, Ph.D.
President, Chief Scientific Officer
President, Chief Scientific Officer
--
--

常见问题

Exicure Inc的前五大股东是谁?

Exicure Inc 的前五大股东如下:Mr. Dongho Lee
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有